← Leaderboards
Artur V Cideciyan
University Of Pennsylvania
$5,096,772
Attributed
$5,096,772
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $577.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,096,772 · 3
By mechanism
R01$3,534,208 · 2
R24$1,562,564 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- William A. Beltran$14,525,140
- Gustavo David Aguirre$22,398,317
- George Preti$517,191
- Ellen W Freeman$12,394,241
- Judith Anesi$722,385
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesFutureOutcome MeasureClinical TrialsVisionRetinitis PigmentosaRetinaMutationBlindnessInherited Retinal DegenerationGene TherapyRpe65 ProteinSuccessBaseRetinalLeadNatural HistoryHuman DiseasePre-ClinicalStagingClinical ResearchAllelesGain Of FunctionClinical Treatment
Grant awards (18)
Photoreceptor Disease in Inherited Retinal Degenerations$577,403
R01 · FY2025 · EY · contact PI
Photoreceptor Disease in Inherited Retinal Degenerations$524,490
R01 · FY2024 · EY · contact PI
Human Rhodopsin-ADRP studies$265,872
R24 · FY2016 · EY · contact PI
Human Rhodopsin-ADRP studies$324,800
R24 · FY2015 · EY · contact PI
Human Rhodopsin-ADRP studies$327,203
R24 · FY2014 · EY · contact PI
Human Rhodopsin-ADRP studies$322,079
R24 · FY2013 · EY · contact PI
Human Rhodopsin-ADRP studies$322,610
R24 · FY2012 · EY · contact PI
Visual Cycle in Human Photoreceptor and RPE Disease$225,958
R01 · FY2012 · EY · contact PI
Visual Cycle in Human Photoreceptor and RPE Disease$225,958
R01 · FY2011 · EY · contact PI
Visual Cycle in Human Photoreceptor and RPE Disease$235,373
R01 · FY2010 · EY · contact PI
Visual Cycle in Human Photoreceptor and RPE Disease$251,750
R01 · FY2009 · EY · contact PI
Visual cycle in human photoreceptor and RPE disease$230,863
R01 · FY2007 · EY · contact PI
Visual cycle in human photoreceptor and RPE disease$232,163
R01 · FY2006 · EY · contact PI
Visual cycle in human photoreceptor and RPE disease$237,750
R01 · FY2005 · EY
VISUAL CYCLE IN HUMAN PHOTORECEPTOR AND RPE DISEASE$198,125
R01 · FY2003 · EY
VISUAL CYCLE IN HUMAN PHOTORECEPTOR AND RPE DISEASE$198,125
R01 · FY2002 · EY
VISUAL CYCLE IN HUMAN PHOTORECEPTOR AND RPE DISEASE$198,125
R01 · FY2001 · EY
VISUAL CYCLE IN HUMAN PHOTORECEPTOR AND RPE DISEASE$198,125
R01 · FY2000 · EY